Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Bilgic-Temel A"'
Publikováno v:
In International Journal of Women's Dermatology July 2019 5(3):158-165
Autor:
Bilgic Temel, Asli, Murrell, Dedee F
Publikováno v:
In Current Opinion in Pharmacology June 2019 46:44-49
Publikováno v:
International Journal of Women's Dermatology, Vol 5, Iss 3, Pp 158-165 (2019)
Leishmaniasis is one of eight neglected tropical diseases currently endemic in 102 countries/areas around the world. In recent years, cutaneous leishmaniasis (CL) has been increasingly observed among migrants, travelers, ecotourists, and military per
Externí odkaz:
https://doaj.org/article/427be84b8b8e4f278ed8626a1bc4617d
Publikováno v:
International Journal of Women's Dermatology, Vol 5, Iss 3, Pp 179-180 (2019)
A 69-year-old woman affected by multiple sclerosis for 35 years was diagnosed with bullous pemphigoid (BP) and treated successfully with dimethyl fumarate (DMF) at a dose of 120 mg twice per day for 7 days and then increased to 240 mg twice per day a
Externí odkaz:
https://doaj.org/article/bc15ce0adaff4937aebaeb864e79d4cf
Autor:
Dicle, Özlem1 (AUTHOR), Bilgic Temel, Asli2 (AUTHOR) aslibilgictemel@gmail.com, Gülkesen, Kemal Hakan3 (AUTHOR)
Publikováno v:
Journal of Cosmetic Dermatology. May2020, Vol. 19 Issue 5, p1071-1077. 7p.
Publikováno v:
Pediatric Dermatology. 36:646-650
Background/objectives There is inadequate knowledge regarding rituximab (RTX) administration in autoimmune bullous diseases (AIBDs), disease prevalence, clinical characteristics, and treatment outcomes within pediatric populations due to the rarity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55eabd74165a2ec8f3ef2c611f900dba
https://doi.org/10.1111/pde.13926
https://doi.org/10.1111/pde.13926
Autor:
Asli Bilgic Temel, Dedee F. Murrell
Publikováno v:
Current Opinion in Pharmacology. 46:44-49
This is an updated review of the literature on the emerging therapeutic options for the treatment of pemphigus to provide better care for patients. There is an increasing range of molecules targeted for pemphigus therapy against CD20, Bruton tyrosine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c85314cffbf86237f7c8c1489a35818
https://doi.org/10.1016/j.coph.2019.01.001
https://doi.org/10.1016/j.coph.2019.01.001
Publikováno v:
Skin Appendage Disord
Background: Autoimmune blistering diseases (AIBD) are characterised by the body’s production of autoantibodies against structural proteins in the epidermis and/or the basement membrane on cutaneous and mucosal surfaces. Alopecia is a complication o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6376f7dfb41694c77f709e12ab207091
https://doi.org/10.1159/000496836
https://doi.org/10.1159/000496836
Autor:
Asli Bilgic-Temel, Soner Uzun
Publikováno v:
Pediatric Autoimmunity and Transplantation ISBN: 9783030262792
Juvenile bullous pemphigoid is characterized by tense blisters that develop on urticarial or normal-appearing skin, while facial and acral involvement is more common in childhood In infants, the lesions are specifically distributed in palms, soles an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68becc36871edd5593cedad82262d2ae
https://doi.org/10.1007/978-3-030-26280-8_63
https://doi.org/10.1007/978-3-030-26280-8_63
Autor:
Asli Bilgic-Temel, Soner Uzun
Publikováno v:
Pediatric Autoimmunity and Transplantation ISBN: 9783030262792
Childhood linear IgA disease (CLAD) also known as childhood chronic bullous dermatosis is characterized by the accumulation of linear IgA along the basal membrane and subepidermal bullae The rash resembles juvenile pemphigoid and often occurs in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b50bef4db7e15466ac32b03d93c9f8d
https://doi.org/10.1007/978-3-030-26280-8_67
https://doi.org/10.1007/978-3-030-26280-8_67